CSS
BVS icon

Cubist Systematic Strategies’s Bioventus BVS Stock Holding History

Cubist Systematic Strategies’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-132,008
Closed -$874K – 3037
2025
Q2 		$874K Sell
132,008
-21,481
-14% -$152K ﹤0.01% 2010
2025
Q1 		$1.4M Buy
153,489
+116,418
+314% +$1.16M 0.01% 1628
2024
Q4 		$389K Sell
37,071
-72,164
-66% -$854K ﹤0.01% 2288
2024
Q3 		$1.31M Buy
109,235
+69,072
+172% +$597K 0.01% 1672
2024
Q2 		$231K Sell
40,163
-9,659
-19% -$53K ﹤0.01% 2457
2024
Q1 		$259K Buy
49,822
+10,399
+26% +$50.8K ﹤0.01% 2947
2023
Q4 		$208K Sell
39,423
-2,215
-5% -$8.77K ﹤0.01% 2986
2023
Q3 		$137K Buy
+41,638
New +$146K ﹤0.01% 2878
2022
Q1 		– Sell
-17,900
Closed -$259K – 3569
2021
Q4 		$259K Buy
17,900
+273
+2% +$3.88K ﹤0.01% 2902
2021
Q3 		$250K Buy
+17,627
New +$271K ﹤0.01% 2458

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Cubist Systematic Strategies's BVS Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Bioventus (BVS) in Q3 2025, closing a stake of 132,008 shares — an estimated $874K sold.

Cubist Systematic Strategies first reported a position in BVS in Q3 2021 and held it in 10 quarters. The position peaked at $1.4M in Q1 2025. 135 funds tracked by Wall St. Rank hold BVS as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Bioventus position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 132,008 Bioventus shares in Q3 2025, an estimated $874K.
  • Cubist Systematic Strategies first reported a position in Bioventus in Q3 2021 and held it in 10 quarters.
  • Cubist Systematic Strategies's Bioventus position peaked at $1.4M in Q1 2025.
  • 135 funds tracked by Wall St. Rank held Bioventus as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.